Search

everythinglearnresearchcommunity

for

Search:↓

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Children's skin diseases and treatments differ from adults and require specific approaches.

Oral Apremilast effectively treats alopecia areata in most patients.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Most adult chronic hair pullers are women who started in their early teens, often have other mental health issues, and may pull hair due to underlying psychiatric conditions.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Using the eye pressure medication latanoprost can cause excessive hair growth and darker eyelashes on the treated eye.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.